Maker Introduction
Hello.
I am Choi Jong-seok, CEO of Lameditech, a company specializing in medical and beauty lasers.

Choi Jong-seok, CEO of Lameditech, decided to develop a "needle-free laser blood collector" after seeing his nephew suffer from diabetes. The daily process of pricking fingertips with a needle was not only painful but also left calluses on his fingers. Watching this, the CEO devoted himself to research with the goal of "less painful blood collection and scar-free recovery," and thus began a life-changing challenge.
The laser blood collector developed by Lameditech minimizes pain during blood collection and allows the wound to heal cleanly without leaving marks. It also reduces the risk of secondary infection, enhancing safety. After ten years of research and product advancement, the technology was recognized on the global stage by winning an Innovation Award at CES, the world's largest electronics show, held in Las Vegas in January 2023.
The result of these efforts isHandyRay-Glu. This product integrates blood collection and blood glucose measurement into a single device, making it easy and convenient for anyone to use.
Product Features
Easy to Use: Simply insert a disposable cap and test strip into the device, place your finger, and press the button. After 3 to 5 seconds, the laser is activated to draw blood, which is then absorbed by the test strip. Five seconds later, your blood glucose level is displayed on the screen.
Smart Integration: Measurement results are automatically synced and recorded with the dedicated app. You can easily track blood glucose changes over time, making management much more systematic.
Innovative Technology: Needle-free blood collection reduces pain and infection risk, and leaves no marks on your fingers—a new approach.
Lameditech is not just a company that makes medical devices, but a company that develops technology to improve the quality of life for patients and their families. HandyRay-Glu will offer diabetes patients a freer and more comfortable daily life.
Why We Chose Wadiz
After ten years of research and product advancement, Lameditech has completed HandyRay-Glu, which combines laser blood collection and blood glucose measurement technologies into one. However, to deliver this innovative technology to more patients, we need a stable production system, international certifications, and funding for global market entry.
Through Wadiz Funding, we aim not only to raise funds, but also to directly hear the voices of diabetes patients and their families and grow together as acommunity of shared values We aim to create this.
Production expansion: We establish a stable supply chain so that more patients can use it.
Technology advancement: We invest in continuous research and development to improve user experience and increase the accuracy of blood sugar management.
Global expansion: Taking the CES Innovation Award as an opportunity, we challenge the global market and promote Korea's medical technology.
Patient-centered value: We position ourselves not just as a simple device, but as a companion that enhances the quality of life for patients.
LaMeditech
